Literature DB >> 16125298

Micro-focal prostate cancer: a comparison of biopsy and radical prostatectomy specimen features.

L M Boccon-Gibod1, O Dumonceau, M Toublanc, V Ravery, L A Boccon-Gibod.   

Abstract

OBJECTIVES: To study the pathologic features of radical prostatectomy (RP) specimens of patients operated on the basis of a potentially "Insignificant" prostate cancer (Ca P) characterized by one single focus (less than 3mm) of moderately differentiated adenocarcinoma - Gleason score < or =6, out of 6-10 biopsies and to determine which characteristics, if any, are predictive of the presence of a "non significant" prostate cancer in the specimen characterized by a low volume (<0.5 ml) moderately differentiated organ confined, cancer (Gleason score less than 6). PATIENTS AND METHODS: PSA, biopsy features, and surgical specimens of a series of 56 patients submitted to RP for "insignificant Ca P" on TRUS prostate biopsies between 1988 and 2004 were compared regarding the number of tumor foci, Gleason grade and score, tumor volume determined by the cylinder method, as well as extraprostatic extension (EPE) and positive surgical margins (P.SM.).
RESULTS: 70% of the patients had multifocal microfocal cancer apart from the index tumor. The presence of grade 4 was ignored by the biopsy in 50% of the cases, however the primary grade was correctly evaluated in more than 70% of the biopsy sets. 42% of the patients had a cancer volume less than 0.5 ml and 29% met the definition of insignificant/unimportant cancer characterized by a moderately differentiated (Gleason score < or =6) of low volume (less than 0.5 ml) however no feature accurately predictive of insignificant cancer could be individualized. In this whole series, only 8% of the patients had EPE. When the pre-operative PSA was <10 ng/ml, 98% of the patients had an organ confined tumor.
CONCLUSION: Patients diagnosed with prostate cancer on the basis of one single focus less than 3 mm of moderately differentiated (Gleason < or =6) prostate cancer have 30% of chances of harboring an insignificant tumor in their prostate and are therefore, at risk of being overtreated, however there is at this time no specific feature able to identify these patients pre operatively.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16125298     DOI: 10.1016/j.eururo.2005.04.033

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  16 in total

1.  The dilemma of multiorgan donors with high serum PSA--a pathologist's proposal.

Authors:  Gregor Mikuz; Rodolfo Montironi; Antonio Lopez-Beltran; Gianni Bussolati
Journal:  Virchows Arch       Date:  2006-05-05       Impact factor: 4.064

2.  Using biopsy to detect prostate cancer.

Authors:  Shahrokh F Shariat; Claus G Roehrborn
Journal:  Rev Urol       Date:  2008

3.  The 20-core prostate biopsy as an initial strategy: impact on the detection of prostatic cancer.

Authors:  Mohamed Amine Jradi; Mohamed Dridi; Mourad Teyeb; Mokhtar Ould Sidi Mohamed; Ramzi Khiary; Samir Ghozzi; Nawfel Ben Rais
Journal:  Can Urol Assoc J       Date:  2010-04       Impact factor: 1.862

4.  Differential gene expression in benign prostate epithelium of men with and without prostate cancer: evidence for a prostate cancer field effect.

Authors:  Michael C Risk; Beatrice S Knudsen; Ilsa Coleman; Ruth F Dumpit; Alan R Kristal; Nolwenn LeMeur; Robert C Gentleman; Lawrence D True; Peter S Nelson; Daniel W Lin
Journal:  Clin Cancer Res       Date:  2010-10-08       Impact factor: 12.531

Review 5.  Saturation biopsies for prostate cancer: current uses and future prospects.

Authors:  Nicolas B Delongchamps; Gabriel P Haas
Journal:  Nat Rev Urol       Date:  2009-11-10       Impact factor: 14.432

Review 6.  Pathologic basis of focal therapy for early-stage prostate cancer.

Authors:  Vladimir Mouraviev; Janice M Mayes; Thomas J Polascik
Journal:  Nat Rev Urol       Date:  2009-04       Impact factor: 14.432

7.  Diagnostic accuracy of extended biopsies for the staging of microfocal prostate cancers in autopsy specimen.

Authors:  N B Delongchamps; G de la Roza; V Chandan; R Jones; G Threatte; M Jumbelic; G P Haas
Journal:  Prostate Cancer Prostatic Dis       Date:  2008-07-15       Impact factor: 5.554

Review 8.  Current status of high-intensity focused ultrasound for prostate cancer: technology, clinical outcomes, and future.

Authors:  François-Joseph L Murat; Albert Gelet
Journal:  Curr Urol Rep       Date:  2008-03       Impact factor: 3.092

Review 9.  Single foci prostate cancer: current diagnosis and management.

Authors:  Ioannis Efthimiou; Konstadinos Skrepetis; Elefteria Bournia
Journal:  Curr Urol       Date:  2013-07-28

10.  Utility of extended pattern prostate biopsies for tumor localization: pathologic correlations after radical prostatectomy.

Authors:  Ryan T Schulte; David P Wood; Stephanie Daignault; Rajal B Shah; John T Wei
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.